In November, IOGP and IPIECA published a position paper on COVID-19 vaccines which aims to help companies understand vaccine efficacy and provides guidance for company policy development aimed at achieving high rates of vaccination amongst staff.
The IOGP-IPIECA joint Health Committee has followed the development, rollout, and real-world efficacy of COVID-19 vaccines since they became available in late 2020. In late 2021, the Health Committee is confident that vaccines provide one of the most effective tools to mitigate the spread and consequences of COVID-19.
